Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Cardiomyopathies (Phase 1/Phase 2)
COVID-19 (Phase 2)
Genetic Diseases, Inborn (Phase 3)
Genetic Diseases, X-Linked (Phase 3)
Heart Failure (Phase 1)
Muscular Diseases (Phase 3)
Muscular Disorders, Atrophic (Phase 3)
Muscular Dystrophies (Phase 3)
Muscular Dystrophy, Duchenne (Phase 3)
Myocardial Infarction (Phase 1/Phase 2)
Myocardial Ischemia (Phase 1)
Nervous System Diseases (Phase 3)
Neuromuscular Diseases (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue